COVID-19 Infection, Melanoma
Conditions
Brief summary
The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.
Detailed description
PRIMARY OBJECTIVES: I. Assess experiences during the COVID-19 pandemic (e.g., exposure, risk factors, testing, isolation, seropositivity, hospitalization, loss of family or friends); COVID-19-specific psychological distress (e.g., fear, anxiety and depressive symptoms); health, financial and social disruptions; perceived benefits and social support; and health-related quality of life (HRQoL) in melanoma patients who participated in protocol PA15-0336. II. Evaluate the extent to which COVID-19 experiences are associated with COVID-19-specific psychological distress, health, financial and social disruptions, perceived benefits and social support, and HRQoL. III. Evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL. IV. Explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL. OUTLINE: Patients complete a survey over 10 minutes.
Interventions
OTHERSurvey Administration
Complete survey
Sponsors
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients who have signed consent for PA15-0336 * Has an active email address and can be contacted via MyChart * Documentation of being alive per the cancer registry
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Experiences during the COVID-19 pandemic | Survey completion Up to 2 months | Including exposure, risk factors, testing, isolation, seropositivity, hospitalization, or loss of family or friends. |
| COVID-19-specific psychological distress | Survey completion Up to 2 months | — |
| COVID-19-specific health | Survey completion Up to 2 months | — |
| COVID-19-specific financial and social disruptions | Survey completion Up to 2 months | — |
| COVID-19-specific perceived benefits and social support | Survey completion Up to 2 months | — |
| COVID-19-specific health related quality of life (HRQoL) | Survey completion Up to 2 months | — |
| Effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL | Survey completion Up to 2 months | Will evaluate the extent to which resiliency factors such as social support and perceived benefits moderate the effects of COVID-19 experiences on COVID-19-specific psychological distress and HRQoL. |
| Prior lifestyle data | Survey completion Up to 2 months | Will explore the association between prior lifestyle data collected as part of PA15-0336 and COVID-19-specific psychological distress and HRQoL. |
Countries
United States
Contacts
CONTACTLorenzo Cohen
PRINCIPAL_INVESTIGATORLorenzo Cohen
M.D. Anderson Cancer Center
Outcome results
None listed